Xi-cheng Wang
Guangzhou, 510006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
An integrated green strategy based on deep eutectic solvents and ultrasound for efficient polyphenol profiling and antioxidant evaluation of dendrobium officinale.
Journal: Ultrasonics sonochemistry
Published: March 24, 2026
SYS6010, epidermal growth factor receptor-targeting antibody-drug conjugate for advanced non-small cell lung cancer: A phase 1 trial.
Journal: Cancer cell
Published: November 25, 2025
Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study.
Journal: Nature cancer
Published: July 23, 2025
Phase I/II Study of Tifcemalimab, an Anti-B- and T-lymphocyte Attenuator Antibody, in Combination with Toripalimab in Previously Treated Advanced Lung Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 03, 2025
Human bone marrow mesenchymal stem cell-derived exosomes loaded with gemcitabine inhibit pancreatic cancer cell proliferation by enhancing apoptosis.
Journal: World journal of gastrointestinal oncology
Published: May 25, 2024
Ferroptosis patterns and tumor microenvironment infiltration characterization in esophageal squamous cell cancer.
Journal: Frontiers in genetics
Published: September 18, 2022
The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial.
Journal: BMC medicine
Published: August 16, 2022
Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 16, 2022
Tanshinone IIA derivatives induced S-phase arrest through stabilizing c-myc G-quadruplex DNA to regulate ROS-mediated PI3K/Akt/mTOR pathway.
Journal: European journal of pharmacology
Published: September 06, 2021
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial.
Journal: Lancet (London, England)
Published: April 19, 2021
Newly synthesized phenanthroimidazole derivatives L082 as a safe anti-tumor and anti-injury inflammation bifunctional compound.
Journal: European journal of pharmacology
Published: April 01, 2020
A phenanthroline derivative enhances radiosensitivity of hepatocellular carcinoma cells by inducing mitochondria-dependent apoptosis.
Journal: European journal of pharmacology
Published: June 29, 2018
Last Updated: 09/26/2026